Literature DB >> 27484503

Patterns of Primary Immunodeficiency Disorders Among a Highly Consanguineous Population: Cairo University Pediatric Hospital's 5-Year Experience.

Nermeen Galal1, Safa Meshaal2, Rabab Elhawary2, Dalia Abd ElAziz3, Radwa Alkady3, Sohilla Lotfy3, Alia Eldash2, Jeanette Boutros3, Aisha Elmarsafy3.   

Abstract

INTRODUCTION: Primary immunodeficiency disorders (PIDs) are heterogeneous disorders that mainly present with severe, persistent, unusual, or recurrent infections in childhood. Reports from different parts of the world indicate a difference between Western and Eastern populations. AIM: The aim of this study was to report on the different patterns of PIDs and identify subgroup characteristics in a highly consanguineous population in Egypt.
METHODS: We performed a retrospective chart review for children below 18 years diagnosed with PID at Cairo University Pediatric Hospital from 2010 to 2014.
RESULTS: Four hundred seventy-six children were diagnosed with PID disorders. Major categories included combined immunodeficiency disorders, which constituted a large proportion (30 %) of cases, along with predominantly antibody disorders (18 %) followed by syndromic combined disorders (16.8 %), phagocytic disorders (13.2 %), immune dysregulation disorders (10.5 %), and autoinflammatory disorders (9 %).
CONCLUSION: PIDs have different patterns within inbred populations with high consanguinity.

Entities:  

Keywords:  Primary immunodeficiency disorders; children; consanguineous populations; patterns

Mesh:

Year:  2016        PMID: 27484503     DOI: 10.1007/s10875-016-0314-1

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  24 in total

Review 1.  Consanguinity and primary immunodeficiencies.

Authors:  Waleed Al-Herz; Hasan Aldhekri; Mohamed-Ridha Barbouche; Nima Rezaei
Journal:  Hum Hered       Date:  2014-07-29       Impact factor: 0.444

2.  Primary Immunodeficiency Diseases in Saudi Arabia: a Tertiary Care Hospital Experience over a Period of Three Years (2010-2013).

Authors:  Bandar Al-Saud; Hamoud Al-Mousa; Sulaiman Al Gazlan; Abdulaziz Al-Ghonaium; Rand Arnaout; Amal Al-Seraihy; Sahar Elshorbagi; Nazeema Elsayed; Jawad Afzal; Hasan Al-Dhekri; Saleh Al-Muhsen
Journal:  J Clin Immunol       Date:  2015-09-22       Impact factor: 8.317

3.  Clinical and genetic heterogeneity of inherited autosomal recessive susceptibility to disseminated Mycobacterium bovis bacille calmette-guérin infection.

Authors:  Houda Elloumi-Zghal; Mohamed Ridha Barbouche; Jalel Chemli; Mohamed Béjaoui; Abdelaziz Harbi; Noureddine Snoussi; Sonia Abdelhak; Koussay Dellagi
Journal:  J Infect Dis       Date:  2002-04-30       Impact factor: 5.226

4.  Defects along the T(H)17 differentiation pathway underlie genetically distinct forms of the hyper IgE syndrome.

Authors:  Shadi Al Khatib; Sevgi Keles; Maria Garcia-Lloret; Elif Karakoc-Aydiner; Ismail Reisli; Hasibe Artac; Yildiz Camcioglu; Haluk Cokugras; Ayper Somer; Necil Kutukculer; Mustafa Yilmaz; Aydan Ikinciogullari; Olcay Yegin; Mutlu Yüksek; Ferah Genel; Ercan Kucukosmanoglu; Ali Baki; Nerin N Bahceciler; Anupama Rambhatla; Derek W Nickerson; Sean McGhee; Isil B Barlan; Talal Chatila
Journal:  J Allergy Clin Immunol       Date:  2009-07-03       Impact factor: 10.793

5.  Chronic granulomatous disease in Israel: clinical, functional and molecular studies of 38 patients.

Authors:  Baruch Wolach; Ronit Gavrieli; Martin de Boer; Giora Gottesman; Josef Ben-Ari; Menachem Rottem; Yechiel Schlesinger; Galia Grisaru-Soen; Amos Etzioni; Dirk Roos
Journal:  Clin Immunol       Date:  2008-08-16       Impact factor: 3.969

Review 6.  Consanguinity and genetic diseases in North Africa and immigrants to Europe.

Authors:  Wagida A Anwar; Meriem Khyatti; Kari Hemminki
Journal:  Eur J Public Health       Date:  2014-08       Impact factor: 3.367

7.  Clinical, functional, and genetic characterization of chronic granulomatous disease in 89 Turkish patients.

Authors:  Mustafa Yavuz Köker; Yıldız Camcıoğlu; Karin van Leeuwen; Sara Şebnem Kılıç; Işıl Barlan; Mustafa Yılmaz; Ayşe Metin; Martin de Boer; Hüseyin Avcılar; Türkan Patıroğlu; Alişan Yıldıran; Olcay Yeğin; Ilhan Tezcan; Özden Sanal; Dirk Roos
Journal:  J Allergy Clin Immunol       Date:  2013-07-31       Impact factor: 10.793

8.  Primary immunodeficiency diseases in Egyptian children: a single-center study.

Authors:  Shereen M Reda; Hanaa M Afifi; Mai M Amine
Journal:  J Clin Immunol       Date:  2008-11-11       Impact factor: 8.317

9.  Primary immunodeficiency diseases in oman: five years' experience at sultan qaboos university hospital.

Authors:  Salem Al-Tamemi; Ibtisam Elnour; David Dennison
Journal:  World Allergy Organ J       Date:  2012-05-15       Impact factor: 4.084

10.  Primary immunodeficiency disorders in Kuwait: first report from Kuwait National Primary Immunodeficiency Registry (2004--2006).

Authors:  Waleed Al-Herz
Journal:  J Clin Immunol       Date:  2007-11-16       Impact factor: 8.317

View more
  12 in total

1.  Genetic Counseling in Primary Immunodeficiency Disorders: An Emerging Experience in Egypt.

Authors:  Rabab E El Hawary; Safa S Meshaal; Dalia S Abd Elaziz; Marwa A Elsharkawy; Radwa S Alkady; Sohilla Lotfy; Ahmad El-Sheikhah; Amr Hassan; Nermeen M Galal; Jeannette A Boutros; Aisha M Elmarsafy
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

Review 2.  Lessons from Genetic Studies of Primary Immunodeficiencies in a Highly Consanguineous Population.

Authors:  Mohamed-Ridha Barbouche; Najla Mekki; Meriem Ben-Ali; Imen Ben-Mustapha
Journal:  Front Immunol       Date:  2017-06-27       Impact factor: 7.561

Review 3.  Primary Immunodeficiency Diseases in Highly Consanguineous Populations from Middle East and North Africa: Epidemiology, Diagnosis, and Care.

Authors:  Hamoud Al-Mousa; Bandar Al-Saud
Journal:  Front Immunol       Date:  2017-06-26       Impact factor: 7.561

4.  Targeted screening for primary immunodeficiency disorders in the neonatal period and early infancy.

Authors:  Nermeen Galal; Mabroka Ohida; Safa Meshaal; Dalia Abd Elaziz; Ismail Elhawary
Journal:  Afr Health Sci       Date:  2019-03       Impact factor: 0.927

5.  Comprehensive Genetic Results for Primary Immunodeficiency Disorders in a Highly Consanguineous Population.

Authors:  Waleed Al-Herz; Janet Chou; Ottavia Maria Delmonte; Michel J Massaad; Wayne Bainter; Riccardo Castagnoli; Christoph Klein; Yenan T Bryceson; Raif S Geha; Luigi D Notarangelo
Journal:  Front Immunol       Date:  2019-01-15       Impact factor: 7.561

6.  A Decade Experience on Severe Combined Immunodeficiency Phenotype in Oman, Bridging to Newborn Screening.

Authors:  Nashat Al Sukaiti; Khwater Ahmed; Jalila Alshekaili; Mahmood Al Kindi; Matthew C Cook; Tariq Al Farsi
Journal:  Front Immunol       Date:  2021-01-15       Impact factor: 7.561

7.  The natural history of ataxia-telangiectasia (A-T): A systematic review.

Authors:  Emily Petley; Alexander Yule; Shaun Alexander; Shalini Ojha; William P Whitehouse
Journal:  PLoS One       Date:  2022-03-15       Impact factor: 3.752

8.  Whole-exome sequencing of T- B+ severe combined immunodeficiency in Egyptian infants, JAK3 predominance and novel variants.

Authors:  R El Hawary; S Meshaal; J Pachlopnik Schmid; A Elmarsafy; A A Mauracher; L Opitz; D Abd Elaziz; S Lotfy; A Eldash; J Boutros; N Galal
Journal:  Clin Exp Immunol       Date:  2020-11-02       Impact factor: 5.732

9.  Poliovirus excretion following vaccination with live poliovirus vaccine in patients with primary immunodeficiency disorders: clinicians' perspectives in the endgame plan for polio eradication.

Authors:  Nermeen M Galal; Safaa Meshaal; Rabab ElHawary; Eman Nasr; Laila Bassiouni; Humayun Ashghar; Noha H Farag; Ondrej Mach; Cara Burns; Jane Iber; Qi Chen; Aisha ElMarsafy
Journal:  BMC Res Notes       Date:  2018-10-11

Review 10.  Newborn Screening for Primary Immunodeficiencies: The Gaps, Challenges, and Outlook for Developing Countries.

Authors:  Zeinab A El-Sayed; Nesrine Radwan
Journal:  Front Immunol       Date:  2020-01-30       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.